Showing results (1-10 of 183) with videos related to
Sort By:
Pageof 19
Vaccines|July 27, 2026
Challenges and Future Perspectives for Vaccines Targeting the Tumor MicroenvironmentDevin B Lowe, Neda Feizi, Walter J StorkusImmunotherapy|October 15, 2011
Chronic inflammation and immunologic-based constraints in malignant diseaseDevin B Lowe, Walter J StorkusOncoimmunology|December 18, 2012
Shock block for improved immunotherapyAparna Rao, Devin B Lowe, Walter J StorkusMethods in Molecular Biology (Clifton, N.J.)|August 24, 2014
Monitoring antigen-specific T cell responses using real-time PCRDevin B Lowe, Jennifer L Taylor, Walter J StorkusMelanoma Research|April 17, 2012
Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma modelAnamika Bose, Devin B Lowe, Aparna Rao, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2012
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivoYanyan Qu, Lu Chen, Devin B Lowe, et al.Oncoimmunology|April 16, 2014
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanomaDevin B Lowe, Anamika Bose, Jennifer L Taylor, et al.NPJ Vaccines|June 23, 2026
Therapeutic DC vaccination against the vascular antigen DLK1 effectively treats primary triple-negative breast cancer and prevents metastasisElizabeth A Daugherity, Caryn Lawrence, Izuchukwu F Okpalanwaka, et al.Expert Opinion on Biological Therapy|January 9, 2003
Dendritic cell-based vaccines and therapies for cancerTomohide Tatsumi, Walter J StorkusFrontiers in Oncology|August 15, 2022
Editorial: Immunotherapy in renal cell carcinomaViktor Gruenwald, Walter J StorkusPageof 19